Literature DB >> 32101706

A Bartonella Effector Acts as Signaling Hub for Intrinsic STAT3 Activation to Trigger Anti-inflammatory Responses.

Isabel Sorg1, Christoph Schmutz1, Yun-Yueh Lu1, Katja Fromm1, Lena K Siewert1, Alexandra Bögli1, Kathrin Strack1, Alexander Harms1, Christoph Dehio2.   

Abstract

Chronically infecting pathogens avoid clearance by the innate immune system by promoting premature transition from an initial pro-inflammatory response toward an anti-inflammatory tissue-repair response. STAT3, a central regulator of inflammation, controls this transition and thus is targeted by numerous chronic pathogens. Here, we show that BepD, an effector of the chronic bacterial pathogen Bartonella henselae targeted to infected host cells, establishes an exceptional pathway for canonical STAT3 activation, thereby impairing secretion of pro-inflammatory TNF-α and stimulating secretion of anti-inflammatory IL-10. Tyrosine phosphorylation of EPIYA-related motifs in BepD facilitates STAT3 binding and activation via c-Abl-dependent phosphorylation of Y705. The tyrosine-phosphorylated scaffold of BepD thus represents a signaling hub for intrinsic STAT3 activation that is independent from canonical STAT3 activation via transmembrane receptor-associated Janus kinases. We anticipate that our findings on a molecular shortcut to STAT3 activation will inspire new treatment options for chronic infections and inflammatory diseases.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bartonella; BepD; EPIYA-related motif; STAT3; anti-inflammatory signaling; bacterial effector; c- Abl; chronic infection; interleukin 10; pro-inflammatory signaling

Year:  2020        PMID: 32101706     DOI: 10.1016/j.chom.2020.01.015

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  8 in total

1.  Identification of the Bartonella autotransporter CFA as a protective antigen and hypervariable target of neutralizing antibodies in mice.

Authors:  Lena K Siewert; Aleksandr Korotaev; Jaroslaw Sedzicki; Katja Fromm; Daniel D Pinschewer; Christoph Dehio
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-17       Impact factor: 12.779

2.  Adaptive immune defense prevents Bartonella persistence upon trans-placental transmission.

Authors:  Lena K Siewert; Christoph Dehio; Daniel D Pinschewer
Journal:  PLoS Pathog       Date:  2022-05-17       Impact factor: 6.823

3.  Bartonella effector protein C mediates actin stress fiber formation via recruitment of GEF-H1 to the plasma membrane.

Authors:  Simon Marlaire; Christoph Dehio
Journal:  PLoS Pathog       Date:  2021-01-28       Impact factor: 6.823

4.  Bartonella type IV secretion effector BepC induces stress fiber formation through activation of GEF-H1.

Authors:  Chunyan Wang; Haoran Zhang; Jiaqi Fu; Meng Wang; Yuhao Cai; Tianyun Ding; Jiezhang Jiang; Jane E Koehler; Xiaoyun Liu; Congli Yuan
Journal:  PLoS Pathog       Date:  2021-01-28       Impact factor: 6.823

Review 5.  The Impact of Bartonella VirB/VirD4 Type IV Secretion System Effectors on Eukaryotic Host Cells.

Authors:  Katja Fromm; Christoph Dehio
Journal:  Front Microbiol       Date:  2021-12-15       Impact factor: 5.640

Review 6.  Turning the Curve Into Straight: Phenogenetics of the Spine Morphology and Coordinate Maintenance in the Zebrafish.

Authors:  Carlos Muñoz-Montecinos; Adrián Romero; Vania Sepúlveda; María Ángela Vira; Karen Fehrmann-Cartes; Sylvain Marcellini; Felipe Aguilera; Teresa Caprile; Ricardo Fuentes
Journal:  Front Cell Dev Biol       Date:  2022-01-26

Review 7.  Undercover Agents of Infection: The Stealth Strategies of T4SS-Equipped Bacterial Pathogens.

Authors:  Arthur Bienvenu; Eric Martinez; Matteo Bonazzi
Journal:  Toxins (Basel)       Date:  2021-10-09       Impact factor: 4.546

8.  Bartonella taylorii: A Model Organism for Studying Bartonella Infection in vitro and in vivo.

Authors:  Katja Fromm; Alexandra Boegli; Monica Ortelli; Alexander Wagner; Erwin Bohn; Silke Malmsheimer; Samuel Wagner; Christoph Dehio
Journal:  Front Microbiol       Date:  2022-07-15       Impact factor: 6.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.